摘要 |
<p>The present invention relates to new thiadiazolidmediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</p> |
申请人 |
ASD THERAPEUTICS PARTNERS LLC |
发明人 |
MEDINA PADILLA, MIGUEL;DOMINGUEZ CORREA, JUAN MANUEL;DE CRISTOBAL BLANCO, JAVIER;FUERTES HUERTA, ANA;SANCHEZ-QUESADA, JORGE;LOPEZ OGALLA, JAVIER;HERRERO SANTOS, SUSANA;PEREZ DE LA CRUZ MORENO, MARIA ANGELES;MARTINEZ MONTERO, OLGA;RODRIGUEZ SALGUERO, BEATRIZ;PALOMO NICOLAU, FRANCISCO |